The United States will begin participating in an international collaboration to distribute COVID-19 vaccines more equitably around the world after President Joe Biden reversed the Trump administration’s withdrawal from the World Health Organization on his first day in office. Richard Marlink, the director of Rutgers Global Health Institute, discusses the impact COVAX, the global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines, will have on ending the COVID-19 pandemic and strengthening global health. To read the full story.
Recent Posts
- Rutgers Researchers Identify Impacts of Russia-Ukraine War on Hospitals.
- Majority of New Jerseyans Worried About Medical and Health Care Costs.
- NJACTS Community Engagement Core COVID-19 Resources
- With Drowning for Children on the Rise, a Rutgers Heath Expert Discusses Water Safety.
- Researcher Teams Up With Teen Champion Figure Skater to Discover Potential Treatments for Addiction Disorders.
Categories
- Community (1,935)
- Covid (970)
- CTO Events (1)
- News (2,478)
- Pilots (20)